Cargando…
Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
Ewing sarcoma (ES) is a rare and aggressive disease that requires multidisciplinary treatment with the use of chemotherapy, radiotherapy, and surgery. Our retrospective study aimed to analyze the prognostic factors and treatment results in different age groups of patients. Between 1998 and 2018, 569...
Autores principales: | Jagodzińska-Mucha, Paulina, Raciborska, Anna, Koseła-Paterczyk, Hanna, Kozak, Katarzyna, Bilska, Katarzyna, Świtaj, Tomasz, Falkowski, Sławomir, Dawidowska, Anna, Rutkowski, Piotr, Ługowska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397138/ https://www.ncbi.nlm.nih.gov/pubmed/34441922 http://dx.doi.org/10.3390/jcm10163627 |
Ejemplares similares
-
Mutational landscape of primary and recurrent Ewing sarcoma
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021) -
The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
por: Kozak, Katarzyna, et al.
Publicado: (2020) -
Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020) -
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014) -
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)